Business Wire

NielsenIQ at Saudi Food Show: How Saudi Arabian Shoppers Successfully Navigate a Sea of Change

31.7.2023 09:00:00 EEST | Business Wire | Press release

Share

The aftershocks of the COVID-19 pandemic and the resultant shifts in the Saudi Arabian retail space, as well as food inflation, have generated a pullback on promotions, coupled with price increases. This has created a challenging environment for Saudi Arabian shoppers who have adapted quickly by shifting towards convenience and essential products.

This was the view of Andrey Dvoychenkov, NielsenIQ Middle East General Manager, as an introduction to the very first Saudi Food Show held in Riyadh and attended by a host of local and international retail professionals. His NielsenIQ presentation entitled Navigating Disruption During Times of Change provided the latest insights into the Saudi Arabian Fast Moving Consumer Goods (FMCG) sector.

Dvoychenkov said; “The Saudi market has recently been driven by price increases, with some prices raised by 10 to 15% during the year, which is mostly due to the rising cost of raw materials.” Dvoychenkov also highlighted the uniqueness of the Saudi Arabian market “where the majority of products and raw materials are imported, making it essential for industry players to navigate supply chain disruptions and consider local substitutes to create more stability.”

Dvoychenkov reported that as a result consumers in Saudi Arabia are scaling back on spending and optimising their budgets due to various lifestyle changes. These changes include cooking at home more often, minimizing waste and spending less on clothing and grooming.

An interesting dynamic is that despite their intention to curtail spending, Saudi shoppers seem to care deeply about quality. The premium product segment is growing ahead of the economy segment for local and international brands in food, with 65% of Saudi shoppers saying they are willing to pay more for quality products.

In terms of their response to the current challenging conditions they face, tactics that consumers are employing include weighing up the attributes that matter most, shopping online to get the best deals, and stopping buying certain categories of products. Interestingly, despite these changes and turbulent times, consumers in Saudi Arabia have the lowest percentage globally in perceiving themselves to be in a recession.

Dvoychenkov indicated that Saudi shoppers primarily spend their shopping time in hypermarkets and supermarkets, but there is a noticeable trend of faster growth in smaller format stores, such as grocery and convenience stores. The price increase in groceries is also significantly lower in these smaller format stores compared to traditional supermarkets.

The essence of "essentials" for modern shoppers

When it comes to choice and product selection, 77% of Saudi shoppers feel that food prices have increased and are only willing to buy essentials. Regarding the definition of "essentials" for modern shoppers, Dvoychenkov emphasized the need to be careful in how this term is perceived. To today's shoppers, essential products include staple items like bread with health benefits, like gluten-free flour that offer intrinsic benefits.

In addition, the NielsenIQ analysis highlighted the growing importance of health and wellness in consumers' minds, with many shoppers in Saudi Arabia willing to pay more for products containing healthy supplements, supporting the immune system, and made with natural ingredients.

The soaring rise of e-commerce and convenience formats

The presentation also revealed a significant 45% growth in online sales (Q1, 2023 vs. a year ago), with e-commerce playing an increasingly important role in the region. Dvoychenkov explained, “e-commerce growth is driven not only by convenience but also by an appetite for discounts. Online platforms offer a wide range of products, including ready-to-eat meals and foods catering to diverse consumer preferences.”

He added, “Convenience formats are also on the rise, with retailers like Viva, Gala, and Tamimi Express actively driving the expansion of these formats, offering everyday low prices and tailored assortments to meet consumers' convenience-seeking needs.”

The retailers' and manufacturers' challenge

With the changing market dynamics, retailers and manufacturers need to adapt their strategies to meet evolving consumer demands. For Saleem Iftikhar*, Country Leader for NielsenIQ in Saudi Arabia: “Price matching, direct price-cutting campaigns, and loyalty-building initiatives are some of the propositions retailers are adopting to cater to price-conscious consumers while providing a pleasant shopping experience.”

The NielsenIQ study finally emphasizes the importance of offering a well-organized store with a pleasant ambience, as well as excellent customer service. “Consumers are increasingly seeking price and promotion-related saving strategies, and although promo efficiency has seen a slight decline, our analysis highlights the need for retailers to engage customers through various components, including price and entertainment,” concludes Dvoychenkov.

* Saleem Iftikhar led a panel discussion with Chris Abboud, PepsiCo, and Shehim Mohammed, Lulu Group, on the first day of Saudi Food Summit - “Mitigating uncertainty, volatility and cost hikes in Food & Beverage industry.”

About NIQ

NIQ is the world’s leading consumer intelligence company, delivering the most complete understanding of consumer buying behaviour and revealing new pathways to growth. In 2023, NIQ combined with GfK, bringing together the two industry leaders with unparalleled global reach. With a holistic retail read and the most comprehensive consumer insights – delivered with advanced analytics through state-of-the-art platforms – NIQ delivers the Full View (TM).

NIQ is an Advent International portfolio company, with operations in 100+ markets, covering more than 90% of the world’s population. For more information, visit www.NIQ.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media
Melina Mammidou (Melina.Mammidou@nielseniq.com)

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye